Initial Clinical Experience with the Endologix AFX Unibody Stent Graft System for Treating Patients with Abdominal Aortic Aneurysms: A Case Controlled Comparative Study

George N Kouvelos, Petroula Nana, Vasilios Bouris, Michalis Peroulis, Aikaterini Drakou, Nikolaos Rousas, Athanasios Giannoukas, Miltiadis I Matsagkas, George N Kouvelos, Petroula Nana, Vasilios Bouris, Michalis Peroulis, Aikaterini Drakou, Nikolaos Rousas, Athanasios Giannoukas, Miltiadis I Matsagkas

Abstract

Purpose: The newly designed unibody AFX endograft system for endovascular aortic aneurysm repair is the only graft with anatomical fixation to the aortic bifurcation in comparison to most other grafts that use the infrarenal neck as the main fixation point. The aim of this study was to assess the preliminary results of the AFX stent-graft system used with infrarenal aortic component and compare them with those obtained in patients treated with a well established endograft of the same material and pure infrarenal fixation as the Gore Excluder.

Materials and methods: A retrospective analysis of prospectively collected data from March 2014 to December 2014 identified 10 elective abdominal aortic aneurysm patients treated with the AFX endograft, in comparison to a matched group of 20 patients treated with the Excluder stent-graft. Endpoints included technical and clinical success, freedom from any secondary intervention, any type of endoleak and aneurysm related death.

Results: Primary technical success was achieved in all patients and no 30-day device related complications or deaths were occurred. The two groups were similar in terms of radiation burden, contrast media, duration of the procedure, post implantation syndrome and in-hospital stay. During a median follow-up period of 23 months (range, 18-26 months) there were no differences in clinical success, freedom from reintervention and aneurysm related death. No type I endoleak was observed in either group. Five of the 6 type II endoleaks (1 in the AFX and 4 in the Excluder group) spontaneously resolved, while in only one patient (Excluder) the endoleak remained without however any change in aneurysm sac diameter (log rank=0.34).

Conclusion: The initial experience with the AFX stent graft system is promising, with successful aneurysm exclusion and good short-term results. Further and larger studies are needed to fully evaluate the sort as well as the long-term results.

Keywords: AFX graft; Aneurysm; Endovascular; Endovascular aortic aneurysm repair.

Figures

Fig. 1
Fig. 1
(A) Preoperative three-dimensional volume-rendered computed tomography reconstruction of an abdominal aortic aneurysm 6.2 cm in diameter. (B) Computed tomography angiography reconstruction 2 years after the procedure.

References

    1. Park BD, Azefor NM, Huang CC, Ricotta JJ. Elective endovascular aneurysm repair in the elderly: trends and outcomes from the nationwide inpatient sample. Ann Vasc Surg. 2014;28:798–807. doi: 10.1016/j.avsg.2013.07.029.
    1. United Kingdom EVAR Trial Investigators. Greenhalgh RM, Brown LC, Powell JT, Thompson SG, Epstein D, et al. Endovascular versus open repair of abdominal aortic aneurysm. N Engl J Med. 2010;362:1863–1871. doi: 10.1056/NEJMoa0909305.
    1. Buckley CJ, Buckley SD. Deficiencies with current aortic endografts. J Cardiovasc Surg (Torino) 2015;56:369–373.
    1. Diethrich EB. Novel sealing concept in the Endologix AFX unibody stent-graft. J Cardiovasc Surg (Torino) 2014;55:93–102.
    1. Melas N, Stavridis K, Saratzis A, Lazarides J, Gitas C, Saratzis N. Active proximal sealing in the endovascular repair of abdominal aortic aneurysms: early results with a new stent-graft. J Endovasc Ther. 2015;22:174–178. doi: 10.1177/1526602815573232.
    1. Skibba AA, Evans JR, Greenfield DT, Yoon HR, Katras T, Ouriel K, et al. Management of late main-body aortic endograft component uncoupling and type IIIa endoleak encountered with the endologix powerlink and AFX platforms. J Vasc Surg. 2015;62:868–875. doi: 10.1016/j.jvs.2015.04.454.
    1. Welborn MB, 3rd, McDaniel HB, Johnson RC, Kennedy RE, Knott A, Mundinger GH, et al. Clinical outcome of an extended proximal seal zone with the AFX endovascular aortic aneurysm system. J Vasc Surg. 2014;60:876–883. doi: 10.1016/j.jvs.2014.04.017. discussion 884.
    1. Chaikof EL, Blankensteijn JD, Harris PL, White GH, Zarins CK, Bernhard VM, et al. Ad Hoc Committee for Standardized Reporting Practices in Vascular Surgery of The Society for Vascular Surgery/American Association for Vascular Surgery. Reporting standards for endovascular aortic aneurysm repair. J Vasc Surg. 2002;35:1048–1060. doi: 10.1067/mva.2002.123763.
    1. Makaroun MS, Tuchek M, Massop D, Henretta J, Rhee R, Buckley C, et al. One year outcomes of the United States regulatory trial of the endurant stent graft system. J Vasc Surg. 2011;54:601–608. doi: 10.1016/j.jvs.2011.03.002.
    1. Scheinert D, Pratesi C, Chiesa R, Coppi G, Brunkwall JS, Klarenbeek G, et al. First-in-human study of the INCRAFT endograft in patients with infrarenal abdominal aortic aneurysms in the INNOVATION trial. J Vasc Surg. 2013;57:906–914. doi: 10.1016/j.jvs.2012.09.079.
    1. Verhoeven EL, Katsargyris A, Bachoo P, Larzon T, Fisher R, Ettles D, et al. GREAT European C3 Module Investigators. Real-world performance of the new C3 gore excluder stent-graft: 1-year results from the European C3 module of the Global Registry for Endovascular Aortic Treatment (GREAT) Eur J Vasc Endovasc Surg. 2014;48:131–137. doi: 10.1016/j.ejvs.2014.04.009.
    1. Carpenter JP, Garcia MJ, Harlin SA, Jordan WD, Jung MT, Krajcer Z, et al. Contemporary results of endovascular repair of abdominal aortic aneurysms: effect of anatomical fixation on outcomes. J Endovasc Ther. 2010;17:153–162. doi: 10.1583/09-2977.1.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner